| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.087 | 0.05 |